CHINWE ANEKWE: Open Payments
NPI 1063148419 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,254 in 419 payments from 19 companies in 2025. Trend: 2023 $970 · 2024 $5,081 · 2025 $8,254
Food & beverage: $8,254
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 61 | $1,290 |
| ABBVIE INC. | 54 | $903 |
| E.R. Squibb & Sons, L.L.C. | 35 | $890 |
| Otsuka America Pharmaceutical, Inc. | 42 | $861 |
| Neurocrine BioSciences, Inc. | 39 | $859 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $563 |
| Janssen Pharmaceuticals, Inc | 24 | $515 |
| Axsome Therapeutics, Inc. | 27 | $501 |
| Alkermes, Inc. | 31 | $465 |
| Lundbeck LLC | 24 | $426 |
Products named: REXULTI, VRAYLAR, INGREZZA, COBENFY, AUSTEDO XR, UZEDY, CAPLYTA, Auvelity.
Industry payments across CA — which companies pay providers there.
